Should we still screen for type 2 diabetes after ADDITION-Cambridge? A low-income world perspective.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Diabetes Research and Clinical Practice

• Publication date

  2013-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.diabres.2013.01.025PMID 23462215
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Global guideline for type 2 diabetes.

  2014cited by this paper
• By the numbers: new estimates from the IDF Diabetes Atlas Update for 2012.

  2012cited by this paper
• Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial

  2012influential reference
• Prevalence and determinants of undiagnosed diabetes in an urban sub-Saharan African population.

  2012cited by this paper
• Screening for hyperglycemia in the developing world: rationale, challenges and opportunities.

  2012cited by this paper
• IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030.

  2011cited by this paper
• Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial

  2011cited by this paper
• Diabetes in sub-Saharan Africa.

  2010cited by this paper
• Screening and prostate-cancer mortality in a randomized European study.

  2009cited by this paper
• HPV screening for cervical cancer in rural India.

  2009cited by this paper
• Intensive glucose control and macrovascular outcomes in type 2 diabetes

  2009cited by this paper
• 10-year follow-up of intensive glucose control in type 2 diabetes.

  2008cited by this paper
• Psychological impact of screening for type 2 diabetes: controlled trial and comparative study embedded in the ADDITION (Cambridge) randomised controlled trial

  2007cited by this paper
• Risk of Cardiovascular and All-Cause Mortality in Individuals With Diabetes Mellitus, Impaired Fasting Glucose, and Impaired Glucose Tolerance: The Australian Diabetes, Obesity, and Lifestyle Study (AusDiab)

  2007cited by this paper
• Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies.

  2007cited by this paper
• Time to stop talking about screening for diabetes?

  2006cited by this paper
• Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin

  2004influential reference
• Subclinical states of glucose intolerance and risk of death in the U.S.

  2001cited by this paper
• Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association.

  1999cited by this paper

• Diabetes Management in Africa

  2019cites this paper
• The economics of type 2 diabetes in middle-income countries

  2017cites this paper
• A community-based lifestyle intervention program for adults with type 2 diabetes mellitus in a low socio-economic status community

  2016cites this paper